title: Virilizing ovarian Leydig cell tumor in a woman with subclinical Cushing syndrome.
abstract: OBJECTIVE
  To report the case of a patient with a virilizing ovarian Leydig cell tumor and subclinical Cushing syndrome attributable to an adrenal adenoma.
  
  
  METHODS
  Detailed clinical, laboratory, radiologic, and pathologic findings are presented, and the pertinent literature is reviewed.
  
  
  RESULTS
  A 49-year-old woman was referred for evaluation of a left adrenal mass (3.0 by 2.4 cm), which had been diagnosed by computed tomographic scan 4 years previously during a work-up for hirsutism. On examination, she had central obesity, facial hirsutism, and male pattern baldness. Work-up showed elevated total and free testosterone levels of 196 ng/dL (reference range, 20 to 70) and 24 pg/mL (1 to 9), respectively. Other results (and reference ranges) were as follows: dehydroepiandrosterone sulfate, 7.5 microg/dL (10 to 221); corticotropin, 12 pg/mL (5 to 50); morning cortisol, 1.4 microg/dL after a 1-mg overnight dexamethasone suppression test; and urine free cortisol, 48.8 microg/24 h (20 to 100). The testosterone level decreased by 14% after a 2-day low-dose dexamethasone suppression test. Findings on transvaginal ovarian ultrasonography and a computed tomographic scan of the pelvis were normal. A laparoscopic adrenalectomy revealed an adrenal adenoma. On the first day postoperatively, the cortisol level was less than 1.0 microg/dL; however, the testosterone level remained elevated. At 6 months postoperatively, a normal result of a cosyntropin stimulation test indicated recovery of the hypothalamic-pituitary-adrenal axis. Bilateral oophorectomy revealed a 1.3-cm right ovarian Leydig cell tumor. Postoperatively, the testosterone level declined to less than 20 ng/dL.
  
  
  CONCLUSIONS
  To our knowledge, this is the first case report of a virilizing ovarian Leydig cell tumor in a patient with subclinical Cushing syndrome.
authors.affiliation: Department of Endocrinology, The Cleveland Clinic, OH 44195, USA.
authors.forename: Dima L
authors.initials: DL
authors.lastname: Diab
authors.forename: Charles
authors.initials: C
authors.lastname: Faiman
authors.forename: Allan E
authors.initials: AE
authors.lastname: Siperstein
authors.forename: William F
authors.initials: WF
authors.lastname: Grossman
authors.forename: Laura O
authors.initials: LO
authors.lastname: Rabinowitz
authors.forename: Amir H
authors.initials: AH
authors.lastname: Hamrahian
mesh_terms: D000236:Adenoma / Q000150:complications / Q000175:diagnosis; D000310:Adrenal Gland Neoplasms / Q000150:complications / Q000175:diagnosis; D003480:Cushing Syndrome / Q000150:complications / Q000175:diagnosis* / Q000209:etiology; D005260:Female; D006801:Humans; D007984:Leydig Cell Tumor / Q000150:complications / Q000175:diagnosis*; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000150:complications / Q000175:diagnosis*; D013739:Testosterone / Q000097:blood; D014770:Virilism / Q000175:diagnosis* / Q000209:etiology
chemical_list: D013739:Testosterone